Assignee
LEE SHEAU LONG
TW·6 granted patents·2 pending applications·15 citations·filing 2007–2021
Top patents by PatentIndex Score
8 records- 0183US7932057B2Method for preparing 20-O-β-D-glucopyranosyl-20(S)-protopanaxadiol (ginsenoside M1) by using sanqi leaves and stemsLEE SHEAU-LONG·Filed 2007·Granted Apr 26, 2011·8 cites·4 claims
- 0282US10172876B2Use of ginsenoside M1 for treating IgA nephropathyLEE SHEAU LONG·Filed 2015·Granted Jan 8, 2019·2 cites·6 claims
- 0380US9844560B2Use of ginsenoside M1 for treating lupus nephritisLEE SHEAU-LONG·Filed 2015·Granted Dec 19, 2017·4 cites·5 claims
- 0471US11524021B2Use of ginsenoside M1 for manufacturing medicament for treating oral cancerLEE SHEAU LONG·Filed 2019·Granted Dec 13, 2022·1 cites·5 claims
- 0550US12508276B2Use of ginsenoside M1 for treating Huntington's diseaseLEE SHEAU LONG·Filed 2019·Granted Dec 30, 2025·0 cites·2 claims
- 0650US2023101022A1Ginsenoside m1 as a modulator of angiotensin regulating enzymes and its use for treating diseases or conditions including symptoms caused by coronavirusLEE SHEAU LONG·Filed 2021·Application pending·0 cites
- 0748US2022218729A1Use of ginsenoside m1 for treating cancerLEE SHEAU LONG·Filed 2020·Application pending·0 cites
- 0841US10357507B2Use of ginsenoside M1 for inhibiting renal fibrosisLEE SHEAU LONG·Filed 2015·Granted Jul 23, 2019·0 cites·5 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →